Secondary haematological malignancies in the BCIRG 001 study. (Q46214254)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

24 February 2020

title

Secondary haematological malignancies in the BCIRG 001 study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

24 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Cagatay Arslan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

24 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

24 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

e87-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(13)70015-9

7 January 2021

Adjuvant docetaxel for node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(13)70015-9

7 January 2021

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(13)70015-9

7 January 2021

Secondary hematological malignancies after breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(13)70015-9

7 January 2021

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(13)70015-9

7 January 2021

Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(13)70015-9

7 January 2021

10.1016/S1470-2045(13)70015-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23452357 AND SRC:MED&resulttype=core&format=json

24 February 2020

1 reference